Conference Menu

Overview
Register
Day 1
Day 2
Short Courses
Posters
Hotel & Travel
Sponsor & Exhibit 

 

Download Brochure:


Clinical Genomics for Cancer Diagnostics
Clinical Genomics for
Cancer Diagnostics
2013 Brochure
 


 

Corporate Sponsors:

Agilent Technologies Logo 
 

Appistry 

 

 

Official Publication:

Bio-IT World 


Lead Sponsoring Publications:

Genengnews 

 

Nature 

 

   ScienceMag 


The Scientist 



Sponsoring Publications:


Drug Discovery News 


Expert Reviews 


Future Oncology 

Insight Pharma Reports 

PharmaVoice 



Web Partners:


Bioscreening 

Biospace 

CanBiotech 

GenomeWeb 

   Labroots  

Schrodinger 


Clinical Genomics for Cancer Diagnostics Conference


Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!


Final Days To Register! 



How can information generated from advanced genomic profiling technology be turned into something clinically actionable? Successfully delivering personalized cancer medicine to patients requires a thorough understanding of how gene expression patterns relate to cancer therapy response as well as the ability to determine which information is most relevant to an individual’s disease. The evolving role of the physician in cancer treatment has become equally important and communicating test results in a concise manner is a largely unmet need.

The Inaugural Clinical Genomics for Cancer Diagnostics meeting will look at novel diagnostic tools and techniques, evaluate their benefit to patient outcome, and focus on steps to implementation. Hotspot testing will be compared to comprehensive genome profiling and emerging technologies will be explored. Considerations for molecular test development, result reporting, and patient stratification will be also addressed. Using genomic information in cancer management presents many operational challenges, but also offers an unprecedented opportunity to take the trial and error out of cancer treatment.

Topics Include:  

  • Interrogating Cancer Genes with NGS-Based Approaches
  • Genotyping Technologies
  • Data Interpretation
  • Moving from Technology to Patient Treatment
  • The Evolving Role of the Patient

 




Keynote Presentation:

 

Integrated Genomic Data Informs Cancer Treatment Elaine Mardis 

Elaine R. Mardis, Ph.D., Professor, Genetics and Molecular Microbiology; Co-Director, The Genome Institute, Washington University School of Medicine at Washington University Medical Center

 



 

 

Who Should Attend:


Pathologists, Oncologists, Medical Directors, Vice Presidents, CMOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in areas such as cancer genomics, bioinformatics, clinical genomics, pharmacogenomics, diagnostics, internal medicine, molecular biology, and translational research.




 


BNK Conjunction logo

By Series:
By Region:


Conference
& Course Catalog

CHI Catalog 


Short Course DVDs